Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:49 PM
Ignite Modification Date:
2025-12-24 @ 9:49 PM
NCT ID:
NCT06398132
Eligibility Criteria:
Inclusion Criteria:
* Be beneficiaries of the Thalidomide Trust
* Be able to communicate in English or via using the British Sign Language as all interview questions and questionnaires are designed in the English language
Exclusion Criteria:
* Inability to give informed consent due to cognitive impairment or otherwise - (capacity levels are already established under General Practitioner (GP) care)
* Inability to understand key aspects of the study due to cognitive impairment or otherwise
* Giving history of critical or terminal co-morbidities such as cancer
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT06398132
Study Brief:
Protocol Section:
NCT06398132